These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4040312

  • 1. [New derivatives of 7- and 8-member perhydrocyclic compounds. II. Studies on the effect on the central nervous system and circulatory system of new derivatives of perhydro-1,4-oxazepine, perhydro-1,4-diazepine, perhydro-1,4,5-oxadiazepine and perhydro-1,5-oxazocine containing the 2-guanidinoethyl group].
    Szadowska A, Działek S, Kiełek MB, Kusowska J, Wejman I.
    Acta Pol Pharm; 1985; 42(1):55-60. PubMed ID: 4040312
    [No Abstract] [Full Text] [Related]

  • 2. [Heterocyclic amine derivatives - analogs of mebanazine, pheniprazine and phenelzine. II. Studies on the effect, on the central nervous system, of derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine, perhydro-1,5-oxazocine and morpholine-containing arylalkyloamine groups].
    Szadowska A, Mazur M, Szmigielski A, Szmigielska H, Winer A.
    Acta Pol Pharm; 1983; 40(1):111-8. PubMed ID: 6136156
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect on the central nervous system and circulatory system of new derivatives of perhydroazepine, perhydro-1,5-oxazocine, morpholine and piperazine containing a pharmacophoric 3-(isopropylamino)-propan-2-ol group].
    Szadowska A, Kiełek MB, Kusowska J, Wejman I.
    Acta Pol Pharm; 1985; 42(5):489-93. PubMed ID: 3834766
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Synthesis and the effect of new perhydro-1,4,7-oxadiazonine derivatives on the central nervous system].
    Mikiciuk-Olasik E, Kotełko B, Szadowska A, Kamińska A.
    Acta Pol Pharm; 1983; 40(4):435-44. PubMed ID: 6687033
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of a library of 3-oxopiperazinium and perhydro-3-oxo-1,4-diazepinium derivatives and identification of bioactive compounds.
    Masip I, Ferrándiz-Huertas C, García-Martínez C, Ferragut JA, Ferrer-Montiel A, Messeguer A.
    J Comb Chem; 2004; 6(1):135-41. PubMed ID: 14714997
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N, Katsuki S, Kawada M.
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract] [Full Text] [Related]

  • 17. [Preliminary studies on the central effects of new derivatives of pyridazino-[1,2a]-1,2,5-triazepine].
    Szadowska A, Mazur M, Działek S, Kiełek MB, Kamińska A.
    Acta Pol Pharm; 1979 Oct; 36(4):497-502. PubMed ID: 532685
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K, Kimura T, Saeki I, Tabata R, Yamazaki S, Eguchi I, Hanazuka M, Horii D, Munt PL, Davis AS.
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.